186 related articles for article (PubMed ID: 21430342)
21. Translating genomic discoveries to the clinic in pediatric oncology.
Glade Bender J; Verma A; Schiffman JD
Curr Opin Pediatr; 2015 Feb; 27(1):34-43. PubMed ID: 25502895
[TBL] [Abstract][Full Text] [Related]
22. Clinical cancer advances 2007: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
Gralow J; Ozols RF; Bajorin DF; Cheson BD; Sandler HM; Winer EP; Bonner J; Demetri GD; Curran W; Ganz PA; Kramer BS; Kris MG; Markman M; Mayer RJ; Raghavan D; Ramsey S; Reaman GH; Sawaya R; Schuchter LM; Sweetenham JW; Vahdat LT; Davidson NE; Schilsky RL; Lichter AS;
J Clin Oncol; 2008 Jan; 26(2):313-25. PubMed ID: 18086794
[TBL] [Abstract][Full Text] [Related]
23. Resistance to Targeted Therapies: Refining Anticancer Therapy in the Era of Molecular Oncology.
Ellis LM; Hicklin DJ
Clin Cancer Res; 2009 Dec; 15(24):7471-7478. PubMed ID: 20008847
[TBL] [Abstract][Full Text] [Related]
24. Methodology of research and practice for the third millennium: evidence-based medicine.
Perez CA
Rays; 2000; 25(3):285-308. PubMed ID: 11367894
[TBL] [Abstract][Full Text] [Related]
25. [Clinical prediction in medical oncology].
González Barón M
An R Acad Nac Med (Madr); 2003; 120(1):135-51; discussion 151-3. PubMed ID: 14560556
[TBL] [Abstract][Full Text] [Related]
26. MR evaluation of response to targeted treatment in cancer cells.
Podo F; Canevari S; Canese R; Pisanu ME; Ricci A; Iorio E
NMR Biomed; 2011 Jul; 24(6):648-72. PubMed ID: 21387442
[TBL] [Abstract][Full Text] [Related]
27. Ovarian cancer biomarkers for molecular biosensors and translational medicine.
Suh KS; Park SW; Castro A; Patel H; Blake P; Liang M; Goy A
Expert Rev Mol Diagn; 2010 Nov; 10(8):1069-83. PubMed ID: 21080822
[TBL] [Abstract][Full Text] [Related]
28. The NCI All Ireland Cancer Conference.
Johnston PG; Daly PA; Liu E
Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
[TBL] [Abstract][Full Text] [Related]
29. Making personalized cancer medicine a reality: challenges and opportunities in the development of biomarkers and companion diagnostics.
Parkinson DR; Johnson BE; Sledge GW
Clin Cancer Res; 2012 Feb; 18(3):619-24. PubMed ID: 22298894
[TBL] [Abstract][Full Text] [Related]
30. Gene expression profiles as an additional tool to conventional predictive factors to assist in management of early endocrine responsive breast cancer.
Chow LW
Expert Opin Investig Drugs; 2010 Apr; 19 Suppl 1():S13-7. PubMed ID: 20374025
[TBL] [Abstract][Full Text] [Related]
31. Drug development for cancer chemoprevention: focus on molecular targets.
Johnson KA; Brown PH
Semin Oncol; 2010 Aug; 37(4):345-58. PubMed ID: 20816505
[TBL] [Abstract][Full Text] [Related]
32. Targeted therapies for non-small cell lung cancer.
Dempke WC; Suto T; Reck M
Lung Cancer; 2010 Mar; 67(3):257-74. PubMed ID: 19914732
[TBL] [Abstract][Full Text] [Related]
33. Beware the Medical-Industrial Complex.
Stevens CW; Glatstein E
Oncologist; 1996; 1(4):IV-V. PubMed ID: 10388005
[TBL] [Abstract][Full Text] [Related]
34. Neoplastic stem cells: a novel therapeutic target in clinical oncology.
Schulenburg A; Ulrich-Pur H; Thurnher D; Erovic B; Florian S; Sperr WR; Kalhs P; Marian B; Wrba F; Zielinski CC; Valent P
Cancer; 2006 Nov; 107(10):2512-20. PubMed ID: 17039500
[TBL] [Abstract][Full Text] [Related]
35. Disease mechanism and biomarkers of oral squamous cell carcinoma.
Brinkman BM; Wong DT
Curr Opin Oncol; 2006 May; 18(3):228-33. PubMed ID: 16552233
[TBL] [Abstract][Full Text] [Related]
36. Cancer stem cell markers in common cancers - therapeutic implications.
Klonisch T; Wiechec E; Hombach-Klonisch S; Ande SR; Wesselborg S; Schulze-Osthoff K; Los M
Trends Mol Med; 2008 Oct; 14(10):450-60. PubMed ID: 18775674
[TBL] [Abstract][Full Text] [Related]
37. Biomarkers in veterinary cancer screening: Applications, limitations and expectations.
Henry CJ
Vet J; 2010 Jul; 185(1):10-4. PubMed ID: 20510636
[TBL] [Abstract][Full Text] [Related]
38. Circulating tumor cells as prognostic marker in metastatic breast cancer.
Andreopoulou E; Cristofanilli M
Expert Rev Anticancer Ther; 2010 Feb; 10(2):171-7. PubMed ID: 20131993
[TBL] [Abstract][Full Text] [Related]
39. Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy.
Lam JS; Shvarts O; Leppert JT; Figlin RA; Belldegrun AS
J Urol; 2005 Jun; 173(6):1853-62. PubMed ID: 15879764
[TBL] [Abstract][Full Text] [Related]
40. Genomics, personalized medicine and cancer practice.
Dancey J
Clin Biochem; 2012 Apr; 45(6):379-81. PubMed ID: 22424082
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
